Xencor

1 follower


Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Industries

Headquarters

Stage

Employees

Links

Org chart

Bassil I. Dahiyat
President, CEO & Director

Bassil I. Dahiyat

Collapse
John R. Desjarlais
EVP, Research & Chief Scientific Officer
Nancy Valente
EVP & Chief Development Officer
John J. Kuch
SVP & CFO
Celia Eckert
SVP, General Counsel & Corporate Secretary
Kirk Rosemark
SVP, Regulatory Affairs & Quality Assurance
Eric P. Kowack
SVP, Program Leadership & Alliance Management
Jeremy Grunstein
VP, Business Development
Jennifer Sandoz
VP, Human Resources
Melissa Long
Director, Contracts & Outsourcing
Mitra Pejman
Associate Director, Clinical Contracts & Outsourcing
Arthur Chirino
Senior Director, Product Control Strategy & Manufacturing
Chet Bohac
Executive Medical Director
Michael Chiarella
Senior Director, Clinical Science
Shahriar Yaghoubi Ph.d.
Director Of Medical Affairs
Theresa Sloma M.D.
Associate Medical Director, Pharmacovigilance
Panida Lertkiatmongkol
Senior Scientist
Veronica Zeng
Principal Scientist
Barbara Hickingbottom J.d., M.d.
Vice President Clinical Development
Norman Barlow
Vice President, Nonclinical & Bioanalytical Development
Jitendra Kanodia
Executive Director Head Of Clinical And Systems Pharmacology
Ccdm Kristy Colella
Associate Director, Clinical Data Management
Tami See
Associate Director, Clinical Data Management
Lingling Li
Senior Manager Biostatistics